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ABSTRACT Calcineurin is a Ca2 and calmodulin-dependent protein phosphatase with diverse cellular functions. Here we
examined the physical and functional interactions between calcineurin and ryanodine receptor (RyR) in a C2C12 cell line
derived from mouse skeletal muscle. Coimmunoprecipitation experiments revealed that the association between RyR and
calcineurin exhibits a strong Ca2 dependence. This association involves a Ca2 dependent interaction between calcineurin
and FK506-binding protein (FKBP12), an accessory subunit of RyR. Pretreatment with cyclosporin A, an inhibitor of
calcineurin, enhanced the caffeine-induced Ca2 release (CICR) in C2C12 cells. This effect was similar to those of FK506 and
rapamycin, two drugs known to cause dissociation of FKBP12 from RyR. Overexpression of a constitutively active form of
calcineurin in C2C12 cells, CnA(391–521) (deletion of the last 131 amino acids from calcineurin), resulted in a decrease in
CICR. This decrease in CICR activity was partially recovered by pretreatment with cyclosporin A. Furthermore, overexpres-
sion of an endogenous calcineurin inhibitor (cain) or an inactive form of calcineurin (CnA(H101Q)) in C2C12 cells resulted in
up-regulation of CICR. Taken together, our data suggest that a trimeric-interaction among calcineurin, FKBP12, and RyR is
important for the regulation of the RyR channel activity and may play an important role in the Ca2 signaling of muscle
contraction and relaxation.
INTRODUCTION
In skeletal muscle, coupling of electrical excitation to in-
tracellular Ca2 release and mechanical contraction (E-C
coupling) occurs at the triad junction between the transverse
tubular invagination of plasma membrane and the terminal
cisternae of sarcoplasmic reticulum (SR) (Rios and Pizarro,
1991). The ryanodine receptor (RyR) located in the SR
membrane is key to this process, functioning as a Ca2
release channel that mediates the mobilization of Ca2 from
the SR store (Franzini-Armstrong and Joregensen, 1994;
Meissner, 1994). The Ca2 release channel is a homotet-
ramer of the 565-kDa RyR polypeptide. Each RyR subunit
is bound by one FK506-binding protein (FKBP12) (Timer-
man et al., 1993; Jayaraman et al., 1992). Ligands that
dissociate the interaction of RyR with FKBP12, such as
FK506 or rapamycin, can enhance the activity of the Ca2
release channel (Ahern et al., 1994; Brillantes et al., 1994;
Chen et al., 1994; Ma et al., 1995). Dissociation of FKBP12
from RyR results in a Ca2 release channel that is activated
by lower concentrations of caffeine (Timerman et al., 1993)
or lower concentration of Ca2 (Timerman et al., 1995),
compared with the normal channel. These biochemical and
functional data suggest that FKBP12, as an accessory part-
ner of RyR, plays a key role in the function of the Ca2
release channel.
Calcineurin is a ubiquitous cytoplasmic serine/threonine
protein phosphatase (Cameron et al., 1995; Clipstone et al.,
1994; Lai et al., 1998) that is present at 10-fold higher
concentration in brain and muscle than in other cell types
(Klee et al., 1988). Calcineurin has been shown to transduce
hypertrophic signals leading to cardiac growth (Molkentin
et al., 1998; Sussman et al., 1998), to mediate the effect of
insulin-like growth factor 1 in skeletal muscle (Musaro et
al., 1999; Semesarian et al., 1999), and to control gene
regulation and cell differentiation in different subtypes of
skeletal muscle (Chin et al., 1998; Dunn et al., 1999; Abbott
et al., 1998). However, whether calcineurin regulates RyR
directly or indirectly in skeletal muscle and how calcineurin
participates in the physiological regulation of the RyR chan-
nel activity remain largely unknown.
In this study, we investigated whether the RyR channel
activity in skeletal muscle can be regulated by calcineurin in
vivo using a mouse skeletal myogenic cell line, C2C12 (Airey
et al., 1991; Lorenzon et al., 2000). We tested the physical and
functional interaction among RyR, FKBP12, and calcineurin in
C2C12 and Chinese hamster ovary (CHO) cells. A Ca2-
dependent interaction between FKBP12 and calcineurin was
identified in C2C12 cells, which mediates calcineurin-depen-
dent regulation of the Ca2 release channel by dephosphory-
lating RyR. Overexpression of cain, an endogenous inhibitor of
calcineurin (Lai et al., 1998), or an inactive form of cal-
cineurin, CnA(H101Q), in C2C12 cells leads to significant
enhancement of the RyR channel activity. Our data suggest
that calcineurin may play important roles in the Ca2 signaling
cycle of muscle contraction and relaxation.
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MATERIALS AND METHODS
Cell culture
C2C12 cells (American Type Culture Collection, Manassas, VA) were
cultured according to established procedures of Airey et al. (1991). Briefly,
C2C12 myoblasts were grown in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum and 1% penicillin-streptomy-
cin. After 2 days, myoblast differentiation was induced by replacing the
medium with Dulbecco’s modified Eagle’s medium supplemented with 2%
horse serum and 1% penicillin-streptomycin. Experiments were performed
on C2C12 myotubes expressing RyR (i.e., from fourth day of culture in
differentiation medium), when it is possible to select myotubes with mature
skeletal-type E-C coupling. CHO cells stably transfected with the rabbit
skeletal muscle RyR were cultured at 37°C and 5% CO2 in Ham’s F-12
medium supplemented with 10% fetal bovine serum, 100 units/mL peni-
cillin, 100 g/mL streptomycin, and 0.1 mg/mL G418 (Bhat et al., 1997).
Immunoprecipitation and Western blot
Confluent C2C12 myotubes or CHO cells growing in 100-mm dish were
harvested and washed twice with ice-cold phosphate-buffered saline, and
lysed in radioimmuno precipitation assay buffer (1  phosphate-buffered
saline, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dode-
cyl sulfate, 0.1 mM phenylmethylsulfonyl fluoride, 1.0 M pepstatin, 1
mM benzamidine, 10 M leupeptin, 1 g/mL aprotinin). Immunoprecipi-
tation was performed with monoclonal anti-RyR antibody (Affinity BioRe-
agents, Golden, CO), or polyclonal anticalcineurin antibody or polyclonal
anti-FKBP12 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA).
Negative controls were done with mouse or rabbit preimmune serum
purchased from Sigma (St. Louis, MO). Immunoprecipitates were recov-
ered with protein G-agarose (Boehringer Mannheim, Indianapolis, IN) and
separated by 3% to 15% gradient sodium dodecyl sulfate-polyacrylamide
gel electrophoresis. Proteins were transferred to a polyvinylidene difluoride
membrane and probed with the above antibodies. The protein-antibody
complexes were then probed with a horseradish peroxidase-linked second-
ary antibody and the signal detected on Kodak films using enhanced
chemiluminescence assay (Pierce, Rockford, IL).
Molecular cloning and mutagenesis
A 1.2-kb EcoR1 fragment containing the amino-terminal portion of cal-
cineurin, (CnA(amino acid 391–512), deletion of 1173–1563 bp of cal-
cineurin) was cloned into the pCMS-EGFP expression vector (Clontech,
Palo Alto, CA), to obtain pCMS-EGFP(CnA). The pCMS-EGFP plasmid
contains two separate promoters that drive the transcription of green-
fluorescent protein (GFP, under SV40 promoter) and the gene of interest
(i.e., CnA, under cytomegalovirus promoter) (Pan et al., 2000). The
CnA cDNA fragment was also ligated to the 5 end of GFP, to create a
CnA-GFP fusion construct. Polymerase chain reaction was used to am-
plify the cDNA encoding amino acids 1881 to 2173 of cain, an endogenous
inhibitor of calcineurin. The polymerase chain reaction product of cain was
ligated to the 3 end of GFP, to create the GFP-c-cain fusion construct.
The QuickChange site-directed mutagenesis kit (Stratagene, La Jolla,
CA) was used to mutate a histidine residue into glutamine (H101Q) in the
pCMS-EGFP(CnA) plasmid to obtain CnA(H101Q). Oligonucleotides
containing the H101Q mutation were synthesized as follows: forward
primer, 5-GTTTGCGGGGACATCCAGGGACAATTCTTTGAC-3 and re-
verse primer, 5-GTCAAAGAATTGTCCCTGGATGTCCCCGCAAAC-3.
After polymerase chain reaction amplification using PfuTurbo DNA
polymerase, the methylated, nonmutated parental DNA template was di-
gested with DpnI. The mutated, nicked dsDNA was transformed into XL-1
Blue supercompetent Escherichia coli. Point mutation of CnA(H101Q)
was confirmed by automated sequencing (Cleveland Genomics, Cleveland,
OH).
Lipofectamine-mediated gene transfection
The various cDNA plasmids (i.e., pCMS-EGFP, pCMS-EGFP(CnA),
pCMS-EGFP(CnA-H101Q), CnA-GFP, GFP-c-cain) were introduced
into the 1.5-day proliferating C2C12 myoblasts, using the Lipofectamine
Plus reagent according to manufacturer’s instructions. To enhance the
transfection efficiency, the incubation time for DNA/lipofectamine com-
plex with cells was set at 6 h. Differentiation of myoblasts was induced by
2% horse serum and 1% penicillin-streptomycin 12 h after transfection.
Myotubes transfected with the genes of interest were selected based on the
appearance of green fluorescent signal monitored with an upright fluores-
cence microscope equipped with filter settings for GFP (excitation wave-
length 488 nm and emission filter set at 510 nm) (Pan et al., 2000).
For subcellular localization of CnA-GFP, mature myotubes expressing
GFP alone or CnA-GFP were fixed with 4% paraformaldehyde and
mounted on glass slides (coated with 0.5% collagen). The GFP signal was
visualized with a Zeiss laser scanning confocal microscope using a 63 oil
immersion objective (Pan et al., 2000).
Intracellular Ca 2 measurement in single cells
C2C12 mytobues were grown in TC3 dishes (Bioptechs, Inc., Butler, PA)
and incubated for 45 min at 37°C in balanced salt solution (BSS): 140 mM
NaCl, 2.8 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, pH 7.2,
containing 5 M Fura 2-AM, and then washed with BSS solution to allow
deesterification of the dye. Using a dual-wavelenghth spectrofluorometer,
with excitation wavelengths at 340 and 380 nm and emission at 510 nm,
fluorescence measurements were performed at 37°C in a temperature-
regulated chamber, mounted on the stage of an inverted fluorescence
microscope (Olympus IX-70). Single-cell fluorescence spectra were con-
tinuously monitored at a sampling frequency of 50 Hz and collected with
a PTI spectrofluorometer (Photon Technology International, Monmouth
Junction, NJ) (Pan et al., 2000). The release of intracellular Ca2 in
individual cells was measured following exposure to 5 mM caffeine in
absence (Ca2 free-BSS containing 0.5 mM EGTA) or presence of extra-
celluar Ca2 (Ca2-BSS containing 2 mM Ca2). Myotubes expressing
GFP were selected under fluorescence filter 488 nm.
Statistical analysis
Values are represented as mean  SE. Significance was determined by
Student’s t-test or analysis of variance. A value of p  0.05 was used as




The interaction between calcineurin and RyR was examined
by testing the ability of an anticalcineurin antibody to co-
immunoprecipitate RyR in differentiated C2C12 cells. The
presence of RyR in the immunoprecipitate was examined by
Western-blot analysis using anti-RyR antibody (Fig. 1 A,
top). Because calcineurin is regulated by Ca2, we investi-
gated whether calcineurin interacts with RyR in a Ca2-
dependent manner. In the presence of 10 mM EGTA, the
association between calcineurin and RyR was diminished
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(lane 3) compared with that in the presence of 10 M Ca2
(lane 4). This suggests that the interaction between the two
proteins requires Ca2. Immunosuppressant drugs FK506
and rapamycin regulate the function of Ca2 release chan-
nel by binding to FKBP12 and causing its dissociation from
RyR (Cameron et al., 1995; Brillantes et al., 1994; Snyder et
al., 1998). The interaction between RyR and calcineurin was
abolished in the presence of FK506 (Fig. 1 A, lane 5) but not
by cyclosporin A, another immunosupressant drug that does
not affect the physical interaction between inositol 1,4,5-
trisphosphate receptor (IP3R) and FKBP12 (9) (lane 6).
Reverse immunoprecipitation experiments were also per-
formed using anti-RyR antibody to pull down calcineurin
(Fig. 1 A, bottom). Similarly, the association between RyR
and calcineurin required the presence of Ca2 and was
diminished by FK506 and EGTA.
Calcineurin is known to be indirectly associated with
RyR through FKBP12 in brain (Cameron et al., 1995) and
heart cells (Bandyopadhyay et al., 2000a). To investigate
the basis of Ca2-dependent interaction between RyR and
calcineurin in skeletal muscle, we first performed immuno-
precipitation experiments with anti-FKBP12 or anti-RyR
antibody in the presence or absence of Ca2, followed by
Western-blot assay (Fig. 1 B). No significant effect of Ca2
was observed in the association between RyR and FKBP12,
as there was no change in the amount of immunoprecipi-
tated proteins in the presence or absence of Ca2 (Fig. 1 B,
lanes 3 and 4). As a control, the interaction between RyR
and FKBP12 was completely abolished by FK506 (lane 5).
We next performed a series of experiments to test the
Ca2-dependent interaction between calcineurin and
FKBP12 (Fig. 1 C). Anti-FKBP12 antibodies (top) or anti-
calcineurin (bottom) were used in the immunoprecipitation
assay with the buffer containing 10 mM EGTA (lane 3), 1
M Ca2 (lane 4), or 10 M Ca2 (lane 5). The presence
of FKBP12 or calcineurin in the immunoprecipitates was
probed with the corresponding antibodies. As Ca2 concen-
tration increased, more FKBP12 or calcineurin appeared in
the immunoprecipitates (Fig. 1 C). This suggests a strong
Ca2-dependence in the interaction between FKBP12 and
calcineurin. Taken together, our data show that the Ca2-
dependent association between RyR and calcineurin origi-
nates from the Ca2-dependent interaction between
FKBP12 and calcineurin.
Effect of calcineurin inhibitors on Ca2 release
from SR
To examine the functional effects of calcineurin and
FKBP12 on the RyR/Ca2 release channel, we examined
the effect of cyclosporin A (CsA), FK506, or rapamycin, on
caffeine-induced Ca2 release in differentiated C2C12
cells. All experiments were performed in Ca2-free medium
to avoid the interference from extracelluar Ca2. We had
FIGURE 1 Ca2-dependent interaction among RyR, FKBP12, and calcineurin in C2C12 myotubes. (A) Cell lysates from differentiated C2C12 myotubes
were incubated with 10 mM EGTA (lane 3), 10 M Ca2 (lane 4), 10 M Ca2 plus 1 M FK506 (lane 5), 10 M Ca2 plus 1 M cyclosporin A (lane
6) for 2 h at 4°C, and subjected to immunoprecipitation (IP) with anticalcineurin (top), or antiryanodine receptor (RyR1) antibody (bottom). Top and bottom
panels represent Western blot probed with anti-RyR or anticalcineurin antibodies, respectively. (B) Coimmuniprecipitation of RyR and FKBP12 in C2C12
myotubes. Top panel shows IP with anti-FKBP12 and Western blot with anti-RyR. Bottom panel shows IP with anti-RyR and Western blot with
anti-FKBP12. (Lane 3) 10 mM EGTA; (lane 4) 10 M Ca2; (lane 5) 10 M Ca2 plus 1 M FK506. (C) Ca2-dependent interaction between calcineurin
and FKBP12. IP with anticalcineurin (top) or anti-FKBP12 antibody (bottom) was performed with buffers containing 10 mM EGTA (lane 3), 1 M Ca2
(lane 4), and 10 M Ca2 (lane 5). Western-blot analysis was performed with anti-FKBP12 (top) or anticalcineurin antibody (bottom), respectively. In all
panels, whole cell homogenates of C2C12 myotubes are shown in lane 1 (positive control), and preimmune serum-treated immunoprecipitates are shown
in lane 2 (negative control). Equal amounts of protein were loaded in each panel.
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previously reported that both CsA and FK506 enhance Ca2
release through the IP3R in COS-7 cells (Bandyopadhyay et
al., 2000b). Caffeine, an effective activator of RyR channels
in skeletal muscle, was found to induce Ca2 release in a
dose-dependent manner (Bhat et al., 1997). At a concentra-
tion of 10 mM or higher, caffeine usually depletes the SR
Ca2 stores in skeletal myotubes. Therefore, we used a
submaximal concentration of caffeine (5 mM) in all subse-
quent functional measurements of intracellular Ca2 release
in C2C12 cells. The following experimental protocol was
used. First, mature myotubes were treated with 5 mM caf-
feine to establish the SR Ca2 release under control condi-
tion. Then, CsA (1 M), FK506 (10 M), or rapamycin (1
M) were incubated to the bath solution for 10 to 15 min,
and the changes in SR Ca2 release were assayed following
stimulation with 5 mM caffeine. The longer incubation time
for these various compounds were necessary for their com-
plete effect on the function of the RyR channel, because
shorter incubation times, e.g., 1 min or 5 min, produced
either no effect or variable results.
The magnitudes of Ca2 release from SR by two sequen-
tial caffeine treatments were comparable (F340/F380 	
0.38  0.02 and 0.41  0.02, n 	 7, for 1st and 2nd
response, respectively) (Fig. 2 A). However, the second
caffeine-induced Ca2 release after treatment with FK506
or rapamycin was significantly higher (Fig. 2, B and C). On
average, the caffeine-induced Ca2 releases after drug treat-
ment were 0.63  0.03 (n 	 6) and 0.64  0.03 (n 	 5) for
FK506 and rapamycin, respectively (Fig. 2 E). Similar to
the effect of FK506 and rapamycin, pretreatment of C2C12
myotubes with CsA also resulted in an increase in the
amplitude of caffeine-induced Ca2 release (F340/F380 	
0.71  0.03, n 	 5) (Fig. 2, D and E).
Effect of constitutively active calcineurin on SR
Ca2 release
The increases in SR Ca2 release function induced by CsA,
FK506, and rapamycin could be due to changes in the
intermolecular interaction between RyR, FKBP12, and cal-
cineurin or could reflect the phosphorylation states of RyR
as a result of changes in phosphatase activity of calcineurin.
To test the latter possibility, we overexpressed a truncated,
constitutively active form of calcineurin (CnA) in C2C12
cells. Calcineurin contains a calmodulin-binding domain
and an autoinhibitory region at the carboxyl-terminal end
(Klee et al., 1988). Deletion of the carboxyl-terminal 131
amino acids from calcineurin, CnA(391–521), leads to
constitutively active phosphatase activity of calcineurin
without the requirement for Ca2 and calmodulin (Shi-
basaki et al., 1996). X-ray crystallographic data show that
the domain of CnA interaction with FKBP12 resides within
the amino-terminal portion of the protein (Griffith et al.,
FIGURE 2 Effects of calcineurin inhibitors on caf-
feine-induced Ca2 release in C2C12 cells. Mature
C2C12 myotubes were loaded with Fura-2 AM Ca2
indicator in 2 mM Ca2-BSS for 10 min. Ca2-
release from SR under control condition was mea-
sured after first application of 5 mM caffeine to a
Ca2-free BSS. After the first caffeine-induced Ca2
release, myotubes were reloaded with 2 mM Ca2-
BSS, with or without drugs for 10 min to ensure
complete loading of Ca2 into SR. The bath solution
was then changed to Ca2-free BSS, followed by a
second addition of 5 mM caffeine. Incubation of 10
M FK506 (B, n 	 6), 1 M rapamycin (C, n 	 5),
or 1 M cyclosporin A (D, n 	 5), to the bath
solution significantly enhanced the second caffeine-
induced Ca2 release, compared with the control (A,
n 	 7). Solid bars indicate the presence of caffeine,
FK506, rapamycin, cyclosporin A, and reloaded
Ca2. Data from multiple experiments are summa-
rized in E as mean  SE. *, significance difference
p  0.05.
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1995; Kissinger et al., 1995). Therefore, the CnA mutant
is unlikely to alter the interaction with FKBP12, and thus it
may provide a direct test to the effect of CnA-mediated
dephosphorylation on the RyR function.
To visualize the expression of CnA, a CnA-GFP fu-
sion construct was used in confocal imaging. As a control,
myotubes were transfected with pEGFP vector encoding
GFP only. The expressed CnA-GFP fusion proteins in
myotubes were abundantly distributed in the cytosol (Fig. 3
B). Based on the GFP fluorescence, we were able to select
the transfected cells and measured their intracellular Ca2.
The caffeine-induced Ca2 transients in cells transfected
with CnA-GFP (F340/F380 	 0.16  0.01, n 	 17, Fig.
3 B) were significantly smaller than those expressing GFP
alone (F340/F380 	 0.37  0.01, n 	 13, Fig. 3 A). This
decreased Ca2 release may result from dephosphorylation
of RyR by the constitutively active calcineurin (CnA); or
alternatively, overexpressed CnA may influence the ex-
pression level of RyR in C2C12 cells, as calcineurin is
known to regulate the transcription of several genes (Abbott
et al., 1998; Olson and Williams, 2000). It is also possible
that the CnA-GFP fusion protein may behave differently
from CnA.
To further test the effect of CnA on the RyR/Ca2
release channel, we cloned the CnA cDNA into a pCMS-
EGFP vector. The pCMS-EGFP(CnA) vector contains an
additional GFP cDNA driven by a separate promotor, thus
allowing visualization of myotubes transfected with CnA
using green fluorescence. Immunoblot analysis revealed the
expression of both exogenous CnA (48 kDa) and endog-
enous wild-type calcineurin (61 kDa) in C2C12 cells (Fig. 4
A). Typically, only 5% to 10% of myotubes can be trans-
FIGURE 3 Transient expression of
CnA-GFP down-regulates caffeine-in-
duced Ca2 release in C2C12 cells. Five
millimolar caffeine-induced Ca2 release
in C2C12 cells transfected with GFP or
CnA-GFP are shown in A and B, re-
spectively. The traces are representative
of 13 to 17 cells in six to eight indepen-
dent experiments. The expression of GFP
and CnA-GFP can be visualized in con-
focal images.
FIGURE 4 Reversible regulation of caffeine-induced Ca2 release in C2C12 cells by CnA. Transient overexpression of CnA in C2C12 myotubes were
detected with anticalcineurin Pan A antibody (A). (Lane 1) Cells transfected with pCMS-EGFP; (lane 2) cells transfected with pCMS-EGFP(CnA).
Arrowheads designate the endogenous calcineurin (61 kDa) band and overexpressed CnA (48 kDa) band. The low intensity of the CnA band reflects
the low transfection efficiency of CnA in C2C12 cells. Myotubes overexpressing CnA exhibited low activity of caffeine-induced Ca2 release (B and
C). After the first caffeine stimulation, cells were incubated with either vehicle (B) or 1 M CsA (C) in 2 mM Ca2-BSS for 10 min. Incubation with 1
M CsA lead to partial reversal of the inhibitory effect of CnA on the RyR channel during the second application of caffeine. The traces are representative
of five independent experiments. Solid bars indicate the presence of caffeine, cyclosporin A, and Ca2.
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fected with exogenous genes using the lipofectamine re-
agent. Therefore, the low level of CnA expression is likely
due to the intrinsic low transfection efficiency of genes in
the myotubes.
As shown in Fig. 4 B, caffeine-induced Ca2 release was
significantly reduced in myotubes overexpressing CnA.
But the CnA-mediated reduction of SR Ca2 release could
be partially recovered by pretreatment of cells with 1 M
CsA (for 10 min) (F340/F380 	 0.33  0.04, n 	 5, Fig. 4
C). These results indicate that the inhibitory effect of CnA
on RyR is due to a direct interaction with the Ca2 release
channel, rather than down regulation of the RyR protein
expression.
Up-regulation of SR Ca2 release by
overexpression of cain and CnA (H101Q)
Cain, also known as cabin-1, is an endogenous noncompet-
itive inhibitor of calcineurin (Lai et al., 1998; Molkentin et
al., 1998; Sun et al., 1998). It is known to bind calcineurin
at a site distinct from the FK506/FKBP12 binding sites. The
calcineurin binding domains of cain are located at amino
acid residues 1881 to 2173 (c-cain), and this portion of cain
can specifically inhibits the phosphatase activity of cal-
cineurin (Lai et al., 1998; Sun et al., 1998). The calcineurin-
inhibitory domain of cain (c-cain, nucleotide 5643–6519)
was fused with GFP at the 3 end to create the GFP-c-cain
fusion construct. The formation of myotubes from myo-
blasts transfected with GFP-c-cain seemed to be delayed
compared with cells transfected with GFP alone (data not
shown). This observation is in agreement with recent reports
demonstrating that cain decreases myogenic differentiation,
myotube fusion, resulting in a decreased number of
multinucleated myotubes (Delling et al., 2000; Friday et al.,
2000). The few multinucleated myotubes expressing GFP-
c-cain were stimulated with 5 mM caffeine in the absence of
extracellular Ca2. The amplitude of peak Ca2 transients
was higher in GFP-c-cain-expressing myotubes (F340/F380
	 0.63  0.03, n 	 12, Fig. 5, bottom) than that in control
cells (F340/F380 	 0.37  0.02, n 	 13, Fig. 5, top),
suggesting that inhibition of endogenous calcineurin phos-
phatase activity can lead to up-regulation of RyR/Ca2
release function.
Mutation of one of the three conserved histidine residues
(H101, H160, or H290) in the active site of calcineurin
results in a catalytically inactive form of calcineurin
(CnA(H101Q)) (Shibasaki et al., 1996). CnA(H101Q)
lacks phosphatase activity of calcineurin without changing
its native structure. Site-directed mutagenesis was used to
generate this catalytically inactive form of CnA by chang-
ing histidine at position 101 into glutamine. Myotubes
transfected with CnA(H101Q) exhibited an enhanced caf-
feine-induced Ca2 release (F340/F380	 0.71 0.06, n	
12, Fig. 6 B, bottom) compared with control myotubes
(F340/F380 	 0.37  0.02, n 	 13, Fig. 6 B, top). The
effect was similar to that of cain. Overexpression of CnA
(H101Q) may in principal compete with the endogenous
calcineurin for binding with RyR and, therefore, prevents
dephosphorylation of RyR by calcineurin.
The results from multiple experiments are summarized in
Fig. 7 A. The effects of calcineurin-related proteins on
FIGURE 5 Up-regulation of caffeine-induced Ca2 release in C2C12
cells by GFP-c-cain. GFP (as control) or GFP-c-cain was transiently
expressed in C2C12 myotubes. Cells expressing GFP-c-cain contained
higher activity of caffeine-induced Ca2 release compared with those
expressing GFP alone. Each trace is representative of 12 to 13 independent
experiments.
FIGURE 6 Up-regulation of caffeine-induced Ca2 release in C2C12
cells by CnA(H101Q). C2C12 myoblasts were transfected with pCMS-
EGFP(CnA(H101Q)) and allowed to differentiate into mature myotubes.
Myotubes overexpressing CnA(H101Q) were selected based on the ap-
pearance of green fluorescence. Those nongreen cells in the same dish were
used as controls. Five millimolar caffeine induced higher activity of SR
Ca2 release in cells expressing CnA(H101Q) (bottom trace) compared
with the controls (top trace). Notice that the kinetics of decay in Ca2
transients were similar between the two groups of cells. The traces are
representative of 12 to 13 independent experiments.
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caffeine-induced Ca2 transients were also studied in the
presence of extracellular Ca2 (2 mM). Fig. 7 B shows that
CnA reduced caffeine-induced Ca2 release (F340/F380
	 0.18  0.01, n 	 10), whereas c-cain and CnA
(H101Q) caused significant increase in caffeine-induced
Ca2 release (F340/F380	 0.92 0.01, n	 5; and 0.93
0.01, n 	 6, respectively) compared with control (F340/
F380 	 0.47  0.01, n 	 6). Clearly, overexpression of
CnA down-regulates the SR Ca2 release channel func-
tion in C2C12 cells, and overexpression of CnA(H101Q)
and GFP-c-cain up-regulates the function of RyR in skeletal
muscle.
Effects of rapamycin on myotubes
overexpressing CnA, GFP-c-cain,
or the CnA (H101Q) proteins
To further test the role of protein-protein interaction in the
function of the Ca2 release channel, we studied the effect
of rapamycin on myotubes transfected with CnA, GFP-c-
cain, CnA(H101Q), respectively. Our data shown in Fig. 2
E demonstrate that rapamycin can enhance the Ca2 release
channel function in C2C12 cells. It may be possible that
rapamycin increases caffeine-triggered Ca2 release by dis-
sociating FKBP12 without affecting the phosphorylation
state of RyR, or that rapamycin causes the dissociation of
FKBP12 and thus the dissociation of CnA. The dissociation
of CnA would allow kinases to rephosphorylate the RyR,
resulting in activation of RyR and hence an increase in
caffeine-triggered Ca2 release, assuming that CnA can
only dephosphorylate RyR when it is bound to the RyR.
As shown in Fig. 8 A, treatment of myotubes with rapa-
mycin (1 M) could reverse the CnA-mediated reduction
of caffeine-induced SR Ca2 release (F340/F380	 0. 35
0.04, n 	 6, rapamycin). This effect is similar to that
observed with CsA (Fig. 4 C), indicating that the action of
the CnA required FKBP12 association with RyR. Inter-
estingly, rapamycin also enhanced the caffeine-induced
Ca2 release in myotubes overexpressing GFP-c-cain (Fig.
8 B) and CnA(H101Q) (Fig. 8 C), respectively. Following
10-min incubation with 1 M rapamycin, the caffeine-
induced Ca release was significantly increased in myotubes
transfected with GFP-c-cain (F340/F380 	 0.87  0.02,
n	 7) and with CnA(H101Q) (F340/F380	 0.93 0.06,
n 	 5).
Because the phosphatase activity of endogenous cal-
cineurin is effectively blocked by overexpression of GFP-
c-cain or CnA (H101Q), the additive effect of rypamycin
FIGURE 7 Effects of CnA, CnA(H101Q), and GFP-c-cain on Ca2 release in C2C12 myotubes. (A) Data from multiple experiments with
caffeine-induced Ca2 release in C2C12 cells expressing CnA, GFP-c-cain, or CnA(H101Q) is presented. The experiments were performed with 0 Ca2
present in the bath solution. (B) Experiments with caffeine-induced Ca2 release in C2C12 cells with 2 mM Ca2 present in the bath solution. Data were
averaged from 5 to 10 independent experiments. *, Significance difference with p  0.05; #, significance difference with p  0.01, compared with control.
(C) Measurement of resting [Ca2] in cells expressing CnA, GFP-c-cain, or CnA(H101Q). Data were averaged from 7 to 14 independent experiments.
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on intracellular Ca release suggests that dissociation of
FKBP12 from RyR by rapamycin and hyperphosphoryla-
tion of RyR through inhibition of calcineurin by GFP-c-cain
or CnA(H101Q) can act synergistically to enhance the
Ca2 release channel activity of RyR in C2C12 cells.
Measurement of sustained cytosolic Ca2 levels
at resting state
Ca2 homeostasis in muscle cells is mainly maintained by
two major proteins, RyR and Ca2-ATPase (SERCA1). It is
possible that some of the changes in SR Ca2 release
induced by calcineurin could reflect the changes in basal
Ca2-ATPase activity on the SR membrane. In separate
experiments, we observed that 20 mM caffeine, a concen-
tration that maximally stimulated the Ca2 release channel,
released similar amount of Ca2 in C2C12 cells irrespective
of their transfection with GFP, CnA, CnA(H101Q), or
GFP-c-cain. In addition, the decaying phase of caffeine-
induced Ca2 release was not very different among all
C2C12 cells tested under the various conditions (i.e., treat-
ment with FK506, CsA, rapamycin, or bearing transfection
with exogenous genes). The results show that calcineurin is
unlikely to affect the Ca2 uptake process into the SR
membrane in C2C12 cells.
As a further test of whether Ca2-ATPase activity is
affected by calcineurin, we monitored cytosolic [Ca2] at
resting state in myotubes transfected with CnA, GFP-c-
cain, or CnA(H101Q). There were no significant differ-
ences in the resting [Ca2] among the C2C12 cells: F340/
F380 	 0.99  0.08 (n 	 14) (control); 1.03  0.12 (n 	
10) (CnA); 0.96  0.07 (n 	 8) (GFP-c-cain); 0.98 
0.10 (n 	 7) (CnA(H101Q)) (Fig. 7 C). Together, our
data suggest that calcineurin does not seem to affect the
Ca2-ATPase activity in C2C12 cells.
Effect of calcineurin in CHO cells stably
transfected with RyR
We have previously reported that RyR stably expressed in
CHO cells (CHO-RyR) exhibits functional properties that
are similar to RyR from native skeletal muscle (Bhat et al.,
1997). CHO cells do not express muscle specific proteins,
such as junctin, triadin, and calsequestrin, but they contain
endogenous FKBP12. Pretreatment of CHO-RyR cells with
10 M FK506 increased the magnitude of Ca2 transient
induced by 100 M ATP or 5 mM caffeine compared with
that of control (data not shown). Therefore, studies with
CHO-RyR cells will provide additional insights on the effects
of calcineurin on RyR (with respect to the role of accessory
proteins and cell-type specific effect of calcineurin).
The various calcineurin-related genes were transiently
transfected into CHO-RyR cells using the lipofectamine
reagent. The presence endogenous calcineurin (61 kDa) in
CHO-RyR cells (Taniguchi et al., 2001) and the presence of
exogenous CnA, CnA(H101Q), and GFP-c-cain ex-
pressed in CHO-RyR cells were confirmed with Western-
blot assay (Fig. 9). Individual transfected CHO cells were
selected based on the appearance of green fluorescent. As
shown in Fig. 10, CnA decreased caffeine-induced Ca2
release from the endoplasmic reticulum (F340/F380 	
0.15  0.03, n 	 8), whereas GFP-c-cain (F340/F380 	
0.72  0.05, n 	 5) and CnA(H101Q) (F340/F380 	
0.75  0.04, n 	 5) significantly enhanced Ca2 release
compared with that of cells transfected with GFP alone
(0.43  0.02, n 	 5). The results with CHO-RyR cells are
similar to those obtained with C2C12 cells.
FIGURE 8 Effect of rapamycin on caffeine-induced Ca2 release in
myotubes overexpressing CnA, CnA(H101Q), or GFP-c-cain. The
CnA, CnA(H101Q), or GFP-c-cain cDNAs cloned into the pCMS-
EGFP plasmid were introduced into C2C12 cells using the lipofectamine
reagent. Ca2-release from SR under control condition was measured after
first application of 5 mM caffeine to a Ca2-free BSS. Following the initial
caffeine-induced Ca2 release, myotubes were reloaded with 2 mM Ca2-
BSS, plus 1 M rapamycin for 10 min, to ensure complete loading of Ca2
into SR. The bath solution was then changed to Ca2-free BSS, followed
by a second addition of 5 mM caffeine. Representative traces with caffeine-
induced Ca2 release in C2C12 cells expressing CnA (A), GFP-c-cain
(B), or CnA(H101Q) (C) are plotted. Each trace is representative of five
to seven independent experiments. The averaged data are presented in the
text.
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DISCUSSION
In the present study, we examined the effect of calcineurin
on the skeletal muscle RyR using a C2C12 skeletal muscle
cell line and a CHO cell line stably transfected with the
skeletal muscle RyR. Coimmunoprecipitation experiments
demonstrated that the association between RyR and cal-
cineurin involves Ca2-dependent interaction between
FKBP12 and calcineurin. This Ca2-dependent interaction
between RyR and calcineurin is similar to previous reports
with the cardiac RyR and calcineurin (Bandyopadhyay et
al., 2000a), and IP3R and calcineurin (Cameron et al.,
1995). A close physical interaction between RyR and cal-
cineurin provides the cellular basis for functional regulation
of the Ca2 release channel by dephosphorylation. The
strong Ca2-dependent interaction between FKBP12 and
calcineurin offers a unique possibility for a feedback regu-
lation of the Ca2 release channel by cytosolic Ca2. This
concept is supported by the fact that maximal catalytic
activity of calcineurin requires a large rise in [Ca2]i (to the
micromolar range) (Stammer and Klee, 1994). Similar
Ca2-dependent regulation of RyR by accessory proteins
has been well documented with calmodulin (Fuentes et al.,
1994; Tripathy et al., 1995; Rodney et al., 2000). It is known
that Ca2-free calmodulin (apocalmodulin) activates the
Ca2 release channel, whereas Ca2-bound calmodulin in-
hibits the Ca2 release channel. The conversion of calmod-
ulin from an activator to an inhibitor is due to Ca2 binding
to calmodulin.
FK506 and rapamycin, ligands that dissociate FKBP12
from RyR, significantly enhanced the caffeine-induced
Ca2 release in C2C12 cells. Cyclosporin A, a direct inhib-
itor of calcineurin had similar effect on caffeine-induced
Ca2 release. Since the major effect of cyclosporin A is to
inhibit the phosphatase activity of calcineurin, the increased
activity of caffeine-induced Ca2 release likely reflects the
reduced dephosphorylation of RyR. Our experiments were
performed at resting status, suggesting that some of the
endogenous calcineurin are active or are associated with
RyR via FKBP12 at resting status, since blocking the en-
FIGURE 9 Expression of CnA, CnA(H101Q), or GFP-c-cain CHO cells. The CnA, CnA(H101Q), or GFP-c-cain cDNAs were introduced into
CHO cells that are permanently transfected with the skeletal muscle RyR using the lipofectamine reagent. (A) Western blot with anti-GFP antibody. (Lane
1) Untransfected CHO-RyR cells; (lane 2) cells transfected with GFP-c-cain. Arrow indicates position of the 57-kDa GFP-c-cain protein. (B) Western blot
with anticalcineurin antibody. (Lane 1) Cells transfected with pCMS-EGFP; (lane 2) cells transfected with CnA; (lane 3) cells transfected with
CnA(H101Q). Arrows indicate position of the CnA and endogenous CnA bands.
FIGURE 10 Effects of CnA, CnA(H101Q) or GFP-c-cain on RyR
stably expressed in CHO cells. (A) Representative traces of Ca2 release
triggered by 5 mM caffeine in CHO-RyR cells transiently expressing GFP
(control), CnA, GFP-c-cain, or CnA(H101Q) (from top to bottom). (B)
Data from multiple experiments are summarized as mean  SE. Data are
from five to eight independent experiments. *, p  0.05 compared with
control; #, p  0.01 compared with control.
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dogenous CnA activity by pharmacological agent (CsA), by
competitive protein inhibitor (GFP-c-cain), or by overex-
pression of a dominant negative mutant (CnA(H101Q)) all
leads to up-regulation of caffeine-induced Ca2 release in
C2C12 cells. The CnA-mediated reduction of caffeine-
induced Ca2 release, on the other hand, was unlikely due
to an effect on the expression level of RyR (Genazzani et
al., 1999), because pretreatment with CsA and rapamycin
can partially reverse the inhibitory effect of CnA on RyR.
Regulations of RyR by various protein kinases and phos-
phatases have been extensively examined by in vitro studies
of lipid bilayer reconstitution of single RyR/Ca2 channel,
radioligand binding of [3H]ryanodine to the isolated RyR
protein, or biochemical assays of RyR phosphorylation by
exogenous or endogenous protein kinases or phosphatases
(Hermann-Frank and Varsanyi, 1993; Hain et al., 1994;
Lokuta et al., 1995; Witcher et al., 1991). Our study with the
C2C12 cells represents the first systematic assay of cal-
cineurin effect on skeletal RyR in native cells. In intact rat
cardiomyocytes, -adrenergic agonists increase PKA activ-
ity, and the ensuring phosphorylation of RyR in cardiac
muscle is responsible for the ionotropic effect of -adren-
ergic agonists on changes in cytosolic [Ca2]i (Hain et al.,
1994; Takasago et al., 1991; Allen and Blinks, 1978). A
recent study by Marx et al. (2000) showed that PKA hyper-
phosphorylation of cardiac RyR could result in an increased
Ca2 sensitivity for activation and elevated single channel
activity by causing dissociation of FKBP12.6 from RyR. Our
data show that inhibition of endogenous calcineurin by CsA,
GFP-c-cain, or CnA (H101Q) leads to up-regulation of caf-
feine-induced Ca2 release in skeletal muscle. Presumably,
inhibition of the phosphatase activity of calcineurin could lead
to hyperphosphorylation of the skeletal muscle RyR and in-
crease in the Ca2 release channel function.
CHO cells transfected with RyR do not express muscle
specific proteins, such as triadin, junctin, or calsequestrin.
Therefore, the use of CHO cells helped us rule out the
possibility that calcineurin interacts other accessory proteins
to regulate the activity of RyR. RyR/Ca2 release channel
expressed in CHO cells can be significantly up-regulated
through transient expression of GFP-c-cain or CnA(H101Q),
and overexpression of CnA leads to down-regulation of
RyR. These data are consistent with the observation in
C2C12 cells that calcineurin can reduce the activity of Ca2
release channel.
Overexpression of CnA, CnA(H101Q), or GFP-c-cain
in C2C12 cells does not appear to affect the function of the
Ca2-ATPase located on the SR membrane, because the
maximal caffeine-releasable Ca2 pool in the SR remained
unchanged, and the Ca2 uptake process following caf-
feine-induced Ca2 release is not significantly affected in
both C2C12 and CHO cells. In addition, the resting cyto-
solic [Ca2] is not changed after overexpression of cal-
cineurin-related genes. These results are in agreement with
our previous studies with CsA on the function of Ca2-
ATPase in rat heart or fast-twitch skeletal muscles (Park et
al., 1999). The difference in oxalate-supported Ca2 uptake
between control and chronic CsA-treated rat heart or fast-
twitch white muscles was negligible, indicating that Ca2-
ATPase activity was not altered by CsA treatment.
Rapamycin, a drug that causes dissociation of FKBP12
from RyR without affecting the phosphatase activity of
calcineurin, was found to enhance the caffeine-induced
Ca2 release in controls myotubes, as well as in myotubes
over expressing CnA, GFP-c-cain, or CnA(H101Q).
These data together demonstrate an important role of pro-
tein-protein interaction in the regulation of intracellular
Ca2 release in muscle cells. Presumably, association of
FKBP12 with RyR exerts an inhibitory role in the function
of the Ca2 release channel, which may or may not depen-
dent on the phosphorylation status of RyR. Anchoring of
calcineurin to RyR via FKBP12 provides spatial coupling
for controlling activity of the Ca2 release channel via
protein dephosphorylation. Also, activation of calcineurin
by Ca2 release from the SR may help to terminate further
intracellular Ca2 release through a negative feedback in-
hibition via dephosphorylation of RyR.
We thank Dr. Takayoshi Kuno and his colleagues for providing cDNA
encoding the rat calcineurin, and Dr. Solomon Snyder for providing the
cain cDNA. We are grateful to Dr. Derek Damron for his generous help
with the Ca2 measurements and to Dr. Salim Hayek, Mr. J.I. Lee, and Mr.
Y. Abdellatif for helpful discussions in preparing the manuscript. This
work was supported by the National Institutes of Health Grants RO1-
AG15556, RO1-CA95739, and RO1-HL69000 (to J.M.), by the Korea
Ministry of Science and Technology Critical Technology 21, 00-J-LF-01-
B-54, by the Korea Science and Engineering Foundation Basic Research
Program, 1999-1-20700-002-5, and by the Brain Korea 21 Project (to D.H.K.).
REFERENCES
Abbott, K. L., B. B. Friday., D. Thaloor., T. J. Murphy, and G. K. Pavlath.
1998. Activation and cellular localization of the cyclosporin A-sensitive
transcriptio factor NF-AT in skeletal muscle cells. Mol. Biol. Cell.
9:2905–2916.
Ahern, G. P., P. R. Junankar, and A. F. Dulhunty. 1994. Single channel
activity of the ryanodine receptor calcium release channel is modulated
by FK-506. FEBS Lett. 352:369–374.
Airey, J. A., M. D. Baring, and J. L. Sutko. 1991. Ryanodine receptor
protein is expressed during differentiation in the muscle cell lines
BC3H1 and C2C12. Dev. Biol. 148:365–374.
Allen, D. G., and J. R. Blinks. 1978. Calcium transients in aequorin-
injected frog cardiac muscle. Nature. 273:509–513.
Bandyopadhyay, A., D. W. Shin., J. O. Ahn, and D. H. Kim. 2000a.
Calcineurin regulates ryanodine receptor/Ca2 release channesl in rat
heart. Biochem. J. 352:61–70.
Bandyopadhyay, A., D. W. Shin, and D. H. Kim. 2000b. Regulation of
ATP-induced calcium release in COS-7 cells by calcineurin. Biochem. J.
348:173–181.
Bhat, M. B., J. Zhao., W. Zang., C. W. Balke., H. Takeshima., W. G. Wier,
and J. Ma. 1997. Caffeine-induced release of intracellular Ca2 from
chinese hamster ovary cells expressing skeletal muscle ryanodine
receptor: Effects on full-length and carboxyl-terminal portion of Ca2
release channels. J. Gen. Physiol. 110:749–762.
Brillantes, A. B., K. Ondrias., A. Scott., E. Kobrinsky., E. Ondriasova.,
M. C. Moschella., T. Jayaraman., M. Landers., B. E. Ehrlich, and A. R.
2548 Shin et al.
Biophysical Journal 83(5) 2539–2549
Marks. 1994. Stabilization of Ca2 release channel (ryanodine recetor)
function by FK506-bidig protein. Cell. 77:513–523.
Cameron, A. M., J. P. Steiner., A. J. Roskams., S. M. Ali., G. V. Ronnett,
and S. H. Snyder. 1995. Calcineurin associates with the inositol 1,4,5-
triphosphate receptor-FKBP12 complex modulate Ca2 flux. Cell. 83:
463–472.
Chen, S. R., L. Zhang, and D. H. MacLennan. 1994. Asymmetrical block-
ade of the Ca2 release channel (ryanodine receptor) by 12-kDa FK506
binding protein. Proc. Natl. Acad. Sci. U. S. A. 91:11953–11957.
Chin, E. R., E. N. Olson., J. A. Richardson., Q. Yang., C. Humphries., J. M.
Shelton., H. Wu., W. Zhu., R. Bassel-Duby, and R. S. Williams. 1998.
A calcineurin-dependent transcriptional pathway controls skeletal mus-
cle fiber type. Genes Dev. 12:2499–2509.
Clipstone, N. A., D. F. Fiorentino, and G. R. Crabtree. 1994. Molecular
analysis of the interaction of calcineurin with drug-immunophilin com-
plexes. J. Biol. Chem. 269:26431–26437.
Delling, U., J. Tureckova., H. W. Lim., L. J. De. Windt, P. Rotwein, and
J. D. Molkentin. 2000. A calcineurin-NFATc3-dependent pathway reg-
ulates skeletal muscle differentiation and slow myosin heavy-chain
expression. Mol. Cell. Biol. 20:6600–6611.
Dunn, S. E., J. L. Bums, and R. N. Michel. 1999. Calcineurin is required
for skeletal muscle hypertrophy. J. Biol. Chem. 274:21908–21912.
Franzini-Armstrong, C., and A. O. Joregensen. 1994. Structure and devel-
opment of E-C coupling units in skeletal muscle. Ann. Rev. Physiol.
56:509–534.
Friday, B. B., V. Horsley, and G. K. Pavlath. 2000. Calcineurin activity is
required for the initiation of skeletal muscle differentiation. J. Cell. Biol.
149:657–665.
Fuentes, O., C. Valdivia., D. Vaughan., R. Coronado, and H. H. Valdivia.
1994. Calcium-dependent block of ryanodine receptor channel of swine
skeletal muscle by direct binding of calmodulin. Cell Calcium. 15:305–316.
Genazzani, A. A., E. Carafoli, and D. Guerini. 1999. Calcineurin controls
inositol 1,4,5-trisphosphate type 1 receptor. Proc. Natl. Acad. Sci.
U. S. A. 96:5797–5801.
Griffith, J. P., J. L. Kim, E. E. Kim, M. D. Sintchak, J. A. Thomson, M. J.
Fitzgibbon, M. A. Fleming, P. R. Caron, K. Hsiao, and M. A. Navia.
1995. X-ray structure of calcineurin inhibited by the immunophilin-
immunosuppressant FKBP12-FK506. Cell. 82:507–522.
Hain, J., S. Nath, M. Mayrleitner, S. Fleischer, and H. Schindler. 1994.
Phosphorylation modulates the function of the calcium release channel of
sarcoplasmic reticulum from skeletal muscle. Biophys. J. 67:1823–1833.
Hermann-Frank, A., and M. Varsanyi. 1993. Enhancement of Ca2 release
channel activity by phosphorylation of the skeletal muscle ryanodine
receptor. FEBS Lett. 332:237–242.
Jayaraman, T., A. M. Brillantes, A. P. Timerman, and S. Fleischer, H.
Erdjument-Bromage, P. Tempst, and A. R. Marks. 1992. FK506 binding
protein associated with the calcium release channel (ryanodine receptor).
J. Biol. Chem. 267:9474–9477.
Kissinger, C. R., H. E. Parge, D. R. Knighton, C. T. Lewis, L. A. Pelletier,
A. Tempczyk, V. J. Kalish, K. D. Tucker, R. E. Showalter, E. W.
Moomaw, L. N. Gastinel, N. Habuka, X. Chen, F. Maldonado, J. E.
Barker, R. Bacquet, and J. E. Villafranca. 1995. Crystal structure of
human calcineurin and the human FKBP12-FK506-calcineurin complex.
Nature. 378:641–644.
Klee, C. B., G. F. Draetta, and M. J. Hubbard. 1988. Calcineurin. Adv.
Enzymol. Relat. Areas. Mol. Biol. 61:149–200.
Lai, M. M., P. E. Burnett, H. Wolosker, S. Blackshaw, and S. H. Snyder.
1998. Cain, a novel physiologic protein inhibitor of calcineurin. J. Biol.
Chem. 273:18325–18331.
Lokuta, A. J., T. B. Rogers, W. J. Lederer, and H. H. Valdivia. 1995.
Modulation of cardiac ryanodine receptors of swine and rabbit by a phos-
phorylation-dephosphorylation mechanism. J. Physiol. 487:609–622.
Lorenzon, P., F. Grohovaz, and F. Ruzzier. 2000. Voltage- and ligand-
gated ryanodine receptors are functionally separated in developing
C2C12 mouse myotubes. J. Physiol. 525:499–507.
Ma, J., M. B. Bhat, and J. Zhao. 1995. Rectification of skeletal muscle
ryanodine receptor mediated by FK506 binding protein. Biophys. J.
69:2398–2404.
Marx, S. O., S. Reiken, Y. Hisamatsu, T. Jayaraman, D. Burkhoff, N.
Rosemblit, and A. R. Marks. 2000. PKA phosphorylation dissociates
FKBP12.6 from the calcium release channel (ryanodine receptor): de-
fective regulation in failing hearts. Cell. 101:365–376.
Meissner, G. 1994. Ryanodine receptor/Ca2 release channels and their
regulation by endogenous effectors. Ann. Rev. Physiol. 56:485–508.
Molkentin, J. D., J. Lu, C. L. Antos, B. Markham, J. Richardson, J.
Robbins, S. Grant, and E. N. Olson. 1998. A calcineurin-dependent
transcriptional pathway for cardiac hypertrophy. Cell. 93:215–228.
Musaro, A., K. J. McCullagh, F. J. Naya, E. N. Olson, and N. Rosenthal.
1999. IGF-1 induces skeletal myocyte hypertrophy through calcineurin
in association with GATA-2 and NF-Atc1. Nature. 400:581–585.
Olson, E. N., and R. S. Williams. 2000. Remodeling muscles with cal-
cineurin. Bioessay. 22:510–519.
Pan, Z., D. Damron, A. Nieminen, M. B. Bhat, and J. Ma. 2000. Depletion
of intracellular Ca2 by caffeine and ryanodine induces apoptosis of
chinese hamster ovary cells transfeted with ryanodine receptor. J. Biol.
Chem. 275:19978–19984.
Park, K. S., T. K. Kim, and D. H. Kim. 1999. Cyclosporin A tratment alters
characteristics of Ca 2 release channel in cardiac sarcoplasmic reticu-
lum. Am. J. Physiol. 276:H865–H872.
Rios, E., and G. Pizarro. 1991. Voltage sensor of excitation-contraction
coupling in skeletal muscle. Physiol. Rev. 71:849–908.
Rodney, G. G., B. Y. Williams, G. M. Strasburg, K. Beckingham, and S. L.
Hamilton. 2000. Regulation of RYR1 activity by Ca2 and calmodulin.
Biochemistry. 39:7807–7812.
Semesarian, C., M. J. Wu, Y. K. Yu, T. Marciniec, T. Yeoh, T. G. Allen,
P. Harvey, and R. M. Graham. 1999. Skeletal muscle hypertrophy is
mediated by a Ca2-dependent calcineurin signaling pathway. Nature.
400:576–581.
Shibasaki, F., E. R. Price, D. Milan, and F. McKeon. 1996. Role of kinases
and the phosphatase calcineurin in the nuclear shuttling of transcription
factor NF-AT4. Nature. 382:370–373.
Snyder, S. H., M. M. Lai, and P. E. Burnett. 1998. Immunophilins in the
nervous system. Neuron. 21:283–294.
Stammer, P. M., and C. B. Klee. 1994. Dual calcium ion regulation of
calcineurin by calmodulin and calcineurin B. Biochemistry. 33:
6859–6866.
Sun, L., H. D. Youn, C. Loh, M. Stolow, W. He, and J. O. Liu. 1998. Cabin
1, a negative regulator for calcineurin signaling in T lymphocytes.
Immunity. 8:703–711.
Sussman, M. A., H. W. Lim, N. Cambon, T. Taigen, E. N. Olson, J.
Robbins, M. C. Colbert, D. F. Wiexzorek, and J. D. Molkentin. 1998.
Prevention of cardiac hypertrophy by calcineurin inhibition. Science.
281:1690–1693.
Takasago, T., T. Imagawa, K. Furukawa, T. Ogurusu, and M. Shigekawa.
1991. Regulation of the cardiac ryanodine receptor by protein kinase-
dependent phosphorylation. J. Biochem. (Tokyo). 109:163–170.
Taniguchi, T., T. Kawamata, H. Mukai, H. Hasegawa, T. Isagawa, M.
Yasuda, T. Hashimoto, A. Terashima, M. Nakai, Y. Ono, and C. Tanaka.
2001. Phosphorylation of Tau is regulated by PKN. J. Biol. Chem.
276:10025–10031.
Timerman, A. P., E. Ogunbumni, E. Freund, G. Wiederrecht, A. R. Marks,
and S. Fleischer. 1993. The calcium release channel of sarcoplasmic
reticulum is modulated by FK-506-binding protein: dissociation and
reconstitution of FKBP-12 to the calcium release channel of skeletal
muscle sarcoplasmic reticulum. J. Biol. Chem. 268:22992–22999.
Timerman, A. P., G. Wiederrecht, A. Marcy, and S. Fleischer. 1995.
Characterization of an exchange reaction between soluble FKBP-12 and
the FKBP.ryanodine receptor complex: modulation by FKBP mutants
deficient in peptidyl-prolyl isomerase activity. J. Biol. Chem. 270:
2451–2549.
Tripathy, A., L. Xu, G. Mann, and G. Meissner. 1995. Calmodulin acti-
vation and inhibition of skeletal muscle Ca2 release channel (ryanodine
receptor). Biophys. J. 69:106–119.
Witcher, D. R., R. J. Kovacs, H. Schulman, D. C. Cefali, and L. R. Jones.
1991. Unique phosphorylation site on the cardiac ryanodine receptor
regulates calcium channel activity. J. Biol. Chem. 266:11144–11152.
Regulation of RyR by Calcineurin 2549
Biophysical Journal 83(5) 2539–2549
